NO331169B1 - Krystallinsk form av et fenyletanolamin, fremstilling derav og farmasoytisk preparat og legemiddel omfattende den samme - Google Patents

Krystallinsk form av et fenyletanolamin, fremstilling derav og farmasoytisk preparat og legemiddel omfattende den samme

Info

Publication number
NO331169B1
NO331169B1 NO20035839A NO20035839A NO331169B1 NO 331169 B1 NO331169 B1 NO 331169B1 NO 20035839 A NO20035839 A NO 20035839A NO 20035839 A NO20035839 A NO 20035839A NO 331169 B1 NO331169 B1 NO 331169B1
Authority
NO
Norway
Prior art keywords
phenylethanolamine
drug
preparation
pharmaceutical composition
same
Prior art date
Application number
NO20035839A
Other languages
English (en)
Other versions
NO20035839L (no
Inventor
Antoine Caron
Olivier Monnier
Jerome Roche
Sabrina Obert
Isabelle Ziri
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20035839L publication Critical patent/NO20035839L/no
Publication of NO331169B1 publication Critical patent/NO331169B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20035839A 2001-06-28 2003-12-29 Krystallinsk form av et fenyletanolamin, fremstilling derav og farmasoytisk preparat og legemiddel omfattende den samme NO331169B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0108562A FR2826651B1 (fr) 2001-06-28 2001-06-28 Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
PCT/FR2002/002235 WO2003002510A1 (fr) 2001-06-28 2002-06-27 Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant

Publications (2)

Publication Number Publication Date
NO20035839L NO20035839L (no) 2004-03-01
NO331169B1 true NO331169B1 (no) 2011-10-24

Family

ID=8864888

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035839A NO331169B1 (no) 2001-06-28 2003-12-29 Krystallinsk form av et fenyletanolamin, fremstilling derav og farmasoytisk preparat og legemiddel omfattende den samme

Country Status (30)

Country Link
US (1) US6992211B2 (no)
EP (1) EP1404641B1 (no)
JP (2) JP4171413B2 (no)
KR (1) KR100869017B1 (no)
CN (1) CN1269797C (no)
AR (1) AR034648A1 (no)
AT (1) ATE403642T1 (no)
AU (1) AU2002333942B2 (no)
BR (1) BR0210661A (no)
CA (1) CA2450213C (no)
CY (1) CY1110099T1 (no)
CZ (1) CZ301450B6 (no)
DE (1) DE60228088D1 (no)
DK (1) DK1404641T3 (no)
EE (1) EE05380B1 (no)
ES (1) ES2307798T3 (no)
FR (1) FR2826651B1 (no)
HK (1) HK1063621A1 (no)
HU (1) HUP0401229A3 (no)
IL (2) IL159134A0 (no)
MX (1) MXPA03011742A (no)
NO (1) NO331169B1 (no)
NZ (1) NZ530140A (no)
PL (1) PL206680B1 (no)
PT (1) PT1404641E (no)
SI (1) SI1404641T1 (no)
SK (1) SK287355B6 (no)
TW (1) TWI286129B (no)
WO (1) WO2003002510A1 (no)
ZA (1) ZA200309512B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
EP1623705A1 (en) * 2004-07-09 2006-02-08 Sanofi-Aventis Use of phenylethanolaminotetralines for preparing anxiolytic drugs
FR2890862B1 (fr) * 2005-09-19 2008-01-25 Sanofi Aventis Sa Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique.
CN108603193B (zh) 2015-12-30 2022-07-22 生物辐射实验室股份有限公司 分裂循环和tape扩增

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198586A (en) * 1987-08-12 1993-03-30 Sanofi Process for the preparation of phenylethanolaminotetralins
US5235103A (en) * 1987-08-12 1993-08-10 Sanofi Process for the preparation of phenylethanolaminotetralins
EP0303546B1 (fr) * 1987-08-12 1994-12-28 Sanofi Procédé pour la O-alkylation de N-(hydroxy)aralkylphényléthanolamines
US5202466A (en) * 1988-06-14 1993-04-13 Sanofi 2-amino-7-hydroxytetraline ethers
US5312961A (en) * 1989-02-14 1994-05-17 Elf Sanofi 2-amino-7-hydroxytetralin carboxylalkyl ethers
FR2648042B1 (fr) * 1989-06-13 1994-06-10 Midy Spa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments pour le traitement des affections oculaires
FR2643076B1 (fr) * 1989-02-14 1991-06-21 Midy Spa Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
FR2669821A1 (fr) * 1990-12-04 1992-06-05 Sanofi Sa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant

Also Published As

Publication number Publication date
JP4799592B2 (ja) 2011-10-26
PL368055A1 (en) 2005-03-21
JP2004530725A (ja) 2004-10-07
KR100869017B1 (ko) 2008-11-17
HK1063621A1 (en) 2005-01-07
EE05380B1 (et) 2011-02-15
EP1404641B1 (fr) 2008-08-06
HUP0401229A3 (en) 2008-03-28
PL206680B1 (pl) 2010-09-30
FR2826651A1 (fr) 2003-01-03
CN1269797C (zh) 2006-08-16
HUP0401229A2 (hu) 2004-10-28
AR034648A1 (es) 2004-03-03
JP4171413B2 (ja) 2008-10-22
JP2009029804A (ja) 2009-02-12
BR0210661A (pt) 2004-10-05
SK287355B6 (sk) 2010-08-09
DE60228088D1 (de) 2008-09-18
CA2450213C (en) 2011-02-15
PT1404641E (pt) 2008-09-22
EE200400007A (et) 2004-02-16
US20040180953A1 (en) 2004-09-16
CZ20033531A3 (en) 2004-04-14
ES2307798T3 (es) 2008-12-01
NZ530140A (en) 2005-05-27
US6992211B2 (en) 2006-01-31
MXPA03011742A (es) 2004-07-01
CZ301450B6 (cs) 2010-03-03
TWI286129B (en) 2007-09-01
SK15932003A3 (sk) 2004-05-04
AU2002333942B2 (en) 2008-02-28
IL159134A0 (en) 2004-05-12
CY1110099T1 (el) 2015-01-14
ZA200309512B (en) 2004-12-08
WO2003002510A1 (fr) 2003-01-09
SI1404641T1 (sl) 2008-10-31
KR20040017817A (ko) 2004-02-27
CA2450213A1 (en) 2003-01-09
DK1404641T3 (da) 2008-12-08
EP1404641A1 (fr) 2004-04-07
NO20035839L (no) 2004-03-01
IL159134A (en) 2009-07-20
ATE403642T1 (de) 2008-08-15
CN1522241A (zh) 2004-08-18
FR2826651B1 (fr) 2005-09-02

Similar Documents

Publication Publication Date Title
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
NO20033143D0 (no) Farmasoytisk preparat
EE200300529A (et) Antraniilhappe amiidid, nende kasutamine ja farmatseutiline preparaat
NO20024175L (no) Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
PT1207867E (pt) Formas de administracao farmaceuticas orais retardadas contendo tramadol
EE200300370A (et) Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
EE200300207A (et) Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
DE60201988D1 (de) Pharmazeutische dosierungsform von amorphem nilfenavir mesylat
NO20031694L (no) Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
PL396568A1 (pl) Krystaliczny bursztynian O-demetylo-wenlafaksyny, kompozycja farmaceutyczna, farmaceutyczna postać dawkowania, doustna postać dawkowania, zastosowanie oraz sposób wytwarzania krystalicznego bursztynianu O-demetylo-wenlafaksyny
NO20035696D0 (no) Krystallinsk anti-cholinergikum, fremgangsmåte for fremstilling derav og anvendelse derav til fremstilling av et legemiddel
EE200300369A (et) Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
DK1478339T3 (da) Farmaceutiske formuleringer af antineoplastiske midler, specielt temozolomid, fremgangsmåder til fremstilling og anvendelse heraf
NO20024176L (no) Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling
NO20035438L (no) Farmasoytisk formulering for effektiv administrering av apomorfin, 6aR-(-)-N-propyl-norapomorfin og deres derivater og prodrugs derav
NO20041607L (no) Doseringsregime og farmasoytisk preparat for nodprevensjon
HUP0401694A3 (en) Crystal forms of a hydrochloride salt of a hydroxynorephedrine derivative, pharmaceutical compositions comprising thereof and use
NO20014738L (no) Tolperisonholdig farmasöytisk preparat for oral administrering
ITMI20011338A0 (it) Composizioni farmaceutiche orali a rilascio immediato del principio attivo
NO20025805D0 (no) Farmasöytisk preparat
NO331227B1 (no) Lineaere basiske forbindelser som har NK-2 antagonistaktivitet, farmasoytiske formuleringer derav og anvendelse av samme for fremstilling av farmasoytiske formuleringer
NO331169B1 (no) Krystallinsk form av et fenyletanolamin, fremstilling derav og farmasoytisk preparat og legemiddel omfattende den samme
EE200200551A (et) Oligosahhariide sisaldav farmatseutiline kompositsioon, oligosahhariidid, nende valmistamine ja raviotstarbeline kasutamine
EE200200480A (et) Memnopeptiidühend, selle valmistamine ja raviotstarbeline kasutamine ning seda sisaldav farmatseutiline kompositsioon
IL158587A0 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees